Suven Life Sciences Limited
1 Business Units - CRAMS, DDDSS, FDC
2 Terms and conditions of appointment of independent directors;
3 Composition of various committees of board of directors
4 Code of conduct of board of directors and senior management personnel
5 Whistle Blower policy
6 Policy on dealing with related party transactions
7 Policy for determining 'material subsidiaries;
8 Details of familiarization programmes imparted to independent directors
9 The email address for grievance redressal and other relevant details;
10 Contact information of the designated officials of the listed entity who are responsible for assisting and handling investor grievances;
11 Financial information
(i) Notice of meeting of the board of directors
(ii) Financial results, on conclusion of the meeting of the board of directors
(iii) Complete copy of the annual report
12 Details of agreements entered into with the media companies and/or their associates, etc;- Nil
13 Presentations made to analysts or institutional investors and submitted to stock exchange;
14 Advertisements in Newspapers
(a) Newspaper Ad of Board Meeting of SUVEN
(b) Newspaper Ad - 3rd Qtr Financial Results 31-12-17

Stock Exchange Submissions for the FY 2017-18

Description Date of Release
Shareholding Pattern_31-12-2017 10-01-2018
Reconciliation of Share Capital Audit Report_31-12-2017 11-01-2018
Shareholding Pattern_30-09-2017 10-10-2017
Reconciliation of Share Capital Audit Report_30-09-2017 12-10-2017
ComplianceCertificate_Reg40(10)_30-09-2017 12-10-2017
Shareholding Pattern_30-06-2017 18-07-2017
Reconciliation of Share Capital Audit Report_30-06-2017 18-07-2017